Source
AutoModeratorMOD•

Please read before commenting.

Keep in mind this is a science sub. Cite your sources appropriately (No news sources, no Twitter, no Youtube). No politics/economics/low effort comments (jokes, ELI5, etc.)/anecdotal discussion (personal stories/info). Please read our full ruleset carefully before commenting/posting.

If you talk about you, your mom, your friends, etc. experience with COVID/COVID symptoms or vaccine experiences, or any info that pertains to you or their situation, you will be banned. These discussions are better suited for the Daily Discussion on r/Coronavirus.

I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.

1
DNAhelicaseMOD•

The title of your post does not contain the source's original title [Rule 3]. Please use a title in accordance with our rule:

"Please post the source title exactly as it appears. Authors, publication journal, and other info should NOT be in the title, but may be posted in the comment section (if necessary)."

1
LordStraboOP•

Prevalence of any symptom at a point in time after infection. Among study participants with COVID-19, 5.0% reported any of 12 common symptoms 12 to 16 weeks after infection; however, prevalence was 3.4% in a control group of participants without a positive test for COVID-19

...

Prevalence of continuous symptoms after infection. Among study participants with COVID-19, 3.0% experienced any of 12 common symptoms for a continuous period of at least 12 weeks from infection, compared with 0.5% in the control group

0
1130wien•

Approach 3: Prevalence of self-reported long COVID.
An estimated 11.7% of study participants with COVID-19 would describe themselves as experiencing long COVID (based on self-classification rather than reporting one of the 12 common symptoms) 12 weeks after infection, and may therefore meet the clinical case definition of post-COVID-19 syndrome, falling to 7.5% when considering long COVID that resulted in limitation to day-to-day activities; these percentages increased to 17.7% and 11.8% respectively when considering only participants who were symptomatic at the acute phase of infection.

0
1130wien•

Approach 2: Prevalence of continuous symptoms after infection.
Among study participants with COVID-19, 3.0% experienced any of 12 common symptoms for a continuous period of at least 12 weeks from infection, compared with 0.5% in the control group; this estimate of 3.0% is based on a similar approach to the one we published in April 2021 (13.7%), but is substantially lower because of a combination of longer study follow-up time and updated statistical methodology. The corresponding prevalence estimate when considering only participants who were symptomatic at the acute phase of infection was 6.7%.

0